Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Arcellx

Biotech & Life Sciences · Gaithersburg, United States · Founded 2015 · IPO 2022 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$6.33B
Market cap · Apr/2026
Revenue
$22M
Latest reported FY

Investors

23 investors on Arcellx's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
NEA
Novo Ventures
Series B+ 21 investors entered at this stage
Cambrian BioPharma
Asymmetry
CaaS Capital Management
Novo Holdings
Quan Capital
Samsara BioCapital
Suvretta Capital Management
CAM Capital
Sixty Degree Capital
Surveyor Capital
Clough Capital Partners
Mirae Asset Capital
Quan Capital
Terra Magnum Capital Partners
Adage Capital
Aju IB Investment
SR One
Soleus Capital
Takeda Ventures
LG Technology Ventures
Mirae Asset Venture Investment

Global footprint

Where Arcellx has talent and traffic

Web traffic by country
12K monthly visits
across markets
🇺🇸 United States58.3%
🇮🇳 India14.2%
🇨🇦 Canada10%
🇯🇵 Japan8.3%
🇵🇭 Philippines5.8%
Top 5 markets shown

See Arcellx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo